Medicine,
Journal Year:
2023,
Volume and Issue:
102(3), P. e32693 - e32693
Published: Jan. 20, 2023
After
the
World
Health
Organization
declared
coronavirus
disease
2019
(COVID-19),
as
a
global
pandemic,
health
workers
have
been
facing
an
unprecedented
and
severe
challenge.
Currently,
mixturetion
to
inhibit
exacerbation
of
pulmonary
inflammation
caused
by
COVID-19,
Fuzheng
Yugan
Mixture
(FZYGM),
has
approved
for
medical
institution
notification.
However,
mechanism
FZYGM
remains
poorly
defined.
This
study
aimed
elucidate
molecular
related
physiological
pathways
potential
therapeutic
agent
COVID-19.
Active
molecules
were
obtained
from
Traditional
Chinese
Medicine
Systems
Pharmacology
Database
Analysis
Platform
(TCMSP),
while
target
genes
COVID-19
identified
DrugBank
GeneCards.
Compound-target
networks
protein-protein
interactions
(PPI)
established
Cytoscape_v3.8.2
String
databases,
respectively.
The
gene
ontology
(GO)
analysis
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
performed.
Finally,
more
in-depth
was
performed
using
docking.
Our
7
active
compounds
3
corresponding
core
targets.
main
potentially
acting
signaling
include
interleukin
(IL)-17
pathway,
tumor
necrosis
factor
(TNF)
Toll-like
receptor
Th17
cell
differentiation,
disease-COVID-19.
shows
that
can
exhibit
anti-COVID-19
effects
through
multiple
targets
pathways.
Therefore,
be
considered
drug
candidate
treatment
it
provides
good
theoretical
support
subsequent
experiments
clinical
applications
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: May 24, 2022
Abstract
Organoids
are
three-dimensional
(3D)
miniature
structures
cultured
in
vitro
produced
from
either
human
pluripotent
stem
cells
(hPSCs)
or
adult
(AdSCs)
derived
healthy
individuals
patients
that
recapitulate
the
cellular
heterogeneity,
structure,
and
functions
of
organs.
The
advent
3D
organoid
systems
is
now
possible
to
allow
remarkably
detailed
observation
cell
morphogens,
maintenance
differentiation
resemble
primary
tissues,
enhancing
potential
study
both
physiology
developmental
stage.
As
they
similar
their
original
organs
carry
genetic
information,
organoids
patient
hold
great
promise
for
biomedical
research
preclinical
drug
testing
currently
used
personalized,
regenerative
medicine,
gene
repair
transplantation
therapy.
In
recent
decades,
researchers
have
succeeded
generating
various
types
mimicking
vivo
Herein,
we
provide
an
update
on
current
technologies
brain,
retinal,
kidney,
liver,
lung,
gastrointestinal,
cardiac,
vascularized
multi-lineage
organoids,
discuss
differences
between
PSC-
AdSC-derived
summarize
applications
cell-derived
laboratory
clinic,
outline
challenges
application
which
would
deepen
understanding
mechanisms
development
enhance
further
utility
basic
clinical
studies.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(3)
Published: May 17, 2023
Organoids
are
three-dimensional
(3D)
miniaturized
versions
of
organs
or
tissues
that
derived
from
cells
with
stem
potential
and
can
self-organize
differentiate
into
3D
cell
masses,
recapitulating
the
morphology
functions
their
in
vivo
counterparts.
Organoid
culture
is
an
emerging
technology,
organoids
various
tissues,
such
as
brain,
lung,
heart,
liver,
kidney,
have
been
generated.
Compared
traditional
bidimensional
culture,
organoid
systems
unique
advantage
conserving
parental
gene
expression
mutation
characteristics,
well
long-term
maintenance
function
biological
characteristics
vitro.
All
these
features
open
up
new
opportunities
for
drug
discovery,
large-scale
screening,
precision
medicine.
Another
major
application
disease
modeling,
especially
hereditary
diseases
difficult
to
model
vitro
modeled
by
combining
genome
editing
technologies.
Herein,
we
introduce
development
current
advances
technology
field.
We
focus
on
applications
basic
biology
clinical
research,
also
highlight
limitations
future
perspectives.
hope
this
review
provide
a
valuable
reference
developments
organoids.
The FASEB Journal,
Journal Year:
2025,
Volume and Issue:
39(4)
Published: Feb. 14, 2025
Abstract
COVID‐19
commonly
leads
to
respiratory
issues,
yet
numerous
patients
also
exhibit
a
diverse
range
of
neurological
conditions,
suggesting
detrimental
impact
SARS‐CoV‐2
or
the
viral
Spike
protein
on
central
nervous
system.
Nonetheless,
molecular
pathway
behind
pathology
and
presumed
neurotropism
remains
largely
unexplored.
We
generated
human
cortical
organoids
(HCOs)
derived
from
induced
pluripotent
stem
cells
(hiPSC)
assess:
(1)
expression
main
entry
factors;
(2)
their
vulnerability
infection;
(3)
infection
exposure
transcriptome.
Results
proved
that
HCOs
express
receptors
co‐receptors;
may
be
productively
infected
by
SARS‐CoV‐2;
particles
released
SARS‐CoV‐2‐infected
are
able
re‐infect
another
cellular
line;
(4)
resulted
in
activation
apoptotic
stress
pathways,
along
with
inflammatory
processes.
Notably,
these
effects
were
recapitulated
when
exposed
alone.
The
data
obtained
demonstrate
likely
infects
probably
through
binding
ACE2,
CD147,
NRP1
factors.
Furthermore,
alone
sufficient
disrupt
homeostasis
induce
neurotoxic
effects,
potentially
contributing
onset
long‐COVID
symptoms.
Journal of Medicinal Chemistry,
Journal Year:
2021,
Volume and Issue:
65(4), P. 2866 - 2879
Published: Sept. 27, 2021
The
emergence
of
a
new
coronavirus,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
presents
an
urgent
public
health
crisis.
Without
available
targeted
therapies,
treatment
options
remain
limited
for
COVID-19
patients.
Using
medicinal
chemistry
and
rational
drug
design
strategies,
we
identify
2-phenyl-1,2-benzoselenazol-3-one
class
compounds
targeting
the
SARS-CoV-2
main
protease
(Mpro).
FRET-based
screening
against
recombinant
Mpro
identified
six
that
inhibit
proteolysis
with
nanomolar
IC50
values.
Preincubation
dilution
experiments
molecular
docking
determined
inhibition
can
occur
by
either
covalent
or
noncovalent
mechanisms,
lead
E04
was
to
competitively.
Lead
E24
inhibited
viral
replication
EC50
value
(844
nM)
in
SARS-CoV-2-infected
Vero
E6
cells
further
confirmed
impair
human
lung
epithelial
human-induced
pluripotent
stem
cell-derived
3D
organoids.
Altogether,
these
studies
provide
structural
framework
mechanism
should
facilitate
future
treatments.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: July 29, 2021
Abstract
The
COVID-19
pandemic
poses
a
global
threat
to
public
health
and
economy.
continuously
emerging
SARS-CoV-2
variants
present
major
challenge
the
development
of
antiviral
agents
vaccines.
In
this
study,
we
identified
that
EK1
cholesterol-coupled
derivative
EK1,
EK1C4,
as
pan-CoV
fusion
inhibitors,
exhibit
potent
activity
against
infection
in
both
lung-
intestine-derived
cell
lines
(Calu-3
Caco2,
respectively).
They
are
also
effective
pseudotyped
B.1.1.7
(Alpha)
B.1.1.248
(Gamma)
well
those
with
mutations
S
protein,
including
N417T,
E484K,
N501Y,
D614G,
which
common
South
African
Brazilian
variants.
Crystal
structure
revealed
targets
HR1
domain
protein
block
virus-cell
provide
mechanistic
insights
into
its
broad
activity.
Nasal
administration
peptides
hACE2
transgenic
mice
significantly
reduced
viral
titers
lung
intestinal
tissues.
showed
good
safety
profiles
various
animal
models,
supporting
further
clinical
EK1-based
inhibitors
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 8, 2022
While
pluripotent
stem
cell-derived
kidney
organoids
are
now
being
used
to
model
renal
disease,
the
proximal
nephron
remains
immature
with
limited
evidence
for
key
functional
solute
channels.
This
may
reflect
early
mispatterning
of
nephrogenic
mesenchyme
and/or
insufficient
maturation.
Here
we
show
that
enhanced
specification
metanephric
progenitors
results
in
elongated
and
radially
aligned
proximalised
nephrons
distinct
S1
-
S3
tubule
cell
types.
Such
PT-enhanced
possess
improved
albumin
organic
cation
uptake,
appropriate
KIM-1
upregulation
response
cisplatin,
expression
SARS-CoV-2
entry
factors
resulting
increased
viral
replication.
The
striking
proximo-distal
orientation
resulted
from
localized
WNT
antagonism
originating
organoid
stromal
core.
represent
an
study
inherited
acquired
tubular
disease
as
well
drug
responses.